Attached files
| file | filename |
|---|---|
| 8-K/A - 8-K - QUESTCOR PHARMACEUTICALS INC | a8-kaproforma.htm |
| EX-99.1 - EXHIBIT - QUESTCOR PHARMACEUTICALS INC | exhibit991.htm |
| EX-99.2 - EXHIBIT - QUESTCOR PHARMACEUTICALS INC | exhibit992.htm |
| EX-22.3 - EXHIBIT - QUESTCOR PHARMACEUTICALS INC | exhibit223.htm |
| EX-99.3 - EXHIBIT - QUESTCOR PHARMACEUTICALS INC | exhibit993proformafinancia.htm |
EXHIBIT INDEX
Exhibit Number | Description | |
23.1 | Consent of ArsenaultBestCameronEllis, Independent Public Accounting Firm | |
99.1 | BioVectra's audited consolidated financial statements for the fiscal year ended August 31, 2012 and 2011 | |
99.2 | BioVectra's unaudited condensed consolidated interim financial statements for the three month periods ended November 30, 2012 and 2011 | |
99.3 | Unaudited pro forma combined balance sheet as of December 31, 2012, statement of income and comprehensive income for the twelve months ended December 31, 2012 and the notes related thereto | |